Hanna Kwiendacz

646 total citations
42 papers, 367 citations indexed

About

Hanna Kwiendacz is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Hanna Kwiendacz has authored 42 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in Hanna Kwiendacz's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (9 papers). Hanna Kwiendacz is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (9 papers). Hanna Kwiendacz collaborates with scholars based in Poland, United Kingdom and Denmark. Hanna Kwiendacz's co-authors include Katarzyna Nabrdalik, Janusz Gumprecht, Gregory Y.H. Lip, Andrzej Tomasik, Karolina Skonieczna‐Żydecka, Igor Łoniewski, Tomasz Stompór, Tomasz Sawczyn, Zenon Brzoza and Agata M. Wijata and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and The American Journal of Cardiology.

In The Last Decade

Hanna Kwiendacz

40 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanna Kwiendacz Poland	9	163	89	71	65	63	42	367
Jiaolong Ma China	12	121 0.7×	83 0.9×	81 1.1×	88 1.4×	33 0.5×	32	382
Shiva Borzouei Iran	13	116 0.7×	46 0.5×	52 0.7×	19 0.3×	31 0.5×	55	357
Takaaki Sato Japan	15	162 1.0×	99 1.1×	62 0.9×	92 1.4×	28 0.4×	50	572
Ramón Sagarra Spain	12	151 0.9×	65 0.7×	44 0.6×	44 0.7×	39 0.6×	22	535
Hamid Reza Aghaei Meybodi Iran	10	88 0.5×	37 0.4×	108 1.5×	34 0.5×	58 0.9×	46	346
Brenda Dorcely United States	8	176 1.1×	55 0.6×	110 1.5×	25 0.4×	54 0.9×	14	344
Zhongai Gao China	9	91 0.6×	48 0.5×	47 0.7×	39 0.6×	27 0.4×	17	282
Bai Chang China	10	130 0.8×	40 0.4×	72 1.0×	41 0.6×	20 0.3×	23	341
Angela Subauste United States	14	100 0.6×	187 2.1×	164 2.3×	39 0.6×	160 2.5×	22	607
Nikheel S. Kolatkar United States	11	139 0.9×	26 0.3×	128 1.8×	98 1.5×	28 0.4×	17	407

Countries citing papers authored by Hanna Kwiendacz

Since Specialization

Citations

This map shows the geographic impact of Hanna Kwiendacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Kwiendacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Kwiendacz more than expected).

Fields of papers citing papers by Hanna Kwiendacz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Kwiendacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Kwiendacz. The network helps show where Hanna Kwiendacz may publish in the future.

Co-authorship network of co-authors of Hanna Kwiendacz

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Kwiendacz. A scholar is included among the top collaborators of Hanna Kwiendacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Kwiendacz. Hanna Kwiendacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwiendacz, Hanna, et al.. (2025). Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project. Cardiovascular Diabetology. 24(1). 76–76. 3 indexed citations

Matejko, Bartłomiej, Katarzyna Cyranka, Katarzyna Nabrdalik, et al.. (2025). Continuous glucose monitoring as a tool for psychological support – exploring metabolic control and psychological well-being after initial cgm implementation in adults with type 1 diabetes. Psychiatria Polska. 1–19.

Nabrdalik, Katarzyna, Hanna Kwiendacz, Igor Łoniewski, et al.. (2024). Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies. BMC Endocrine Disorders. 24(1). 206–206. 5 indexed citations

Kwiendacz, Hanna, Justyna Kulpa, Frans Coenen, et al.. (2024). Artificial intelligence‐enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes. Diabetes Obesity and Metabolism. 26(7). 2624–2633. 3 indexed citations

Nabrdalik, Katarzyna, Yanda Meng, Hanna Kwiendacz, et al.. (2024). Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study. Cardiovascular Diabetology. 23(1). 296–296. 3 indexed citations

Mantovani, Marta Sílvia Maria, Hanna Kwiendacz, Tommaso Bucci, et al.. (2024). Metabolically “extremely unhealthy” obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project. Cardiovascular Diabetology. 23(1). 326–326. 6 indexed citations

Kwiendacz, Hanna, Katarzyna Nabrdalik, Agata M. Wijata, et al.. (2023). Relationship of vitamin D deficiency to cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: The Silesia Diabetes-Heart Project. Polskie Archiwum Medycyny Wewnętrznej. 133(6).

Cyranka, Katarzyna, Hanna Kwiendacz, Katarzyna Nabrdalik, et al.. (2023). Evaluation of Psychological Resources of Young Adults With Type 1 Diabetes Mellitus During the Transition From Pediatric to Adult Diabetes Clinics: Multicenter Cross-sectional Study. JMIR Formative Research. 7. e46513–e46513. 2 indexed citations

Kwiendacz, Hanna, Agata M. Wijata, Justyna Kulpa, et al.. (2023). Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project. Cardiovascular Diabetology. 22(1). 4 indexed citations

10.

Nabrdalik, Katarzyna, et al.. (2023). The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes. Endokrynologia Polska. 5 indexed citations

11.

Nabrdalik, Katarzyna, Andrzej Tomasik, Hanna Kwiendacz, et al.. (2023). Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status. Scientific Reports. 13(1). 250–250. 2 indexed citations

12.

Nabrdalik, Katarzyna, Hanna Kwiendacz, Karolina Skonieczna‐Żydecka, et al.. (2023). Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet). Biomedicine & Pharmacotherapy. 168. 115650–115650. 6 indexed citations

13.

Nabrdalik, Katarzyna, et al.. (2022). Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach. Cardiovascular Diabetology. 21(1). 240–240. 48 indexed citations

14.

Nabrdalik, Katarzyna, Hanna Kwiendacz, Tomasz Sawczyn, et al.. (2021). Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study. Oxidative Medicine and Cellular Longevity. 2021(1). 5593589–5593589. 17 indexed citations

15.

Kwiendacz, Hanna, Katarzyna Nabrdalik, Tomasz Stompór, & Janusz Gumprecht. (2020). What do we know about biomarkers in diabetic kidney disease?. Endokrynologia Polska. 71(6). 545–550. 2 indexed citations

16.

Kwiendacz, Hanna, Katarzyna Nabrdalik, Piotr Adamczyk, et al.. (2020). Association of single nucleotide polymorphism (rs741301) of the ELMO1 gene with diabetic kidney disease in Polish patients with type 2 diabetes: a pilot study. Endokrynologia Polska. 71(1). 66–72. 6 indexed citations

17.

Kwiendacz, Hanna, et al.. (2019). An unusual use of personal insulin pump by a patient with type 1 diabetes on a ketogenic diet — a case report. Clinical Diabetology. 8(4). 223–226. 2 indexed citations

18.

Nabrdalik, Katarzyna, Hanna Kwiendacz, Andrzej Tomasik, et al.. (2018). Diabetes-Related Knowledge of Polish National Mountain Leaders. High Altitude Medicine & Biology. 19(3). 237–243. 2 indexed citations

19.

Nabrdalik, Katarzyna, Hanna Kwiendacz, Tomasz Sawczyn, et al.. (2018). Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study. International Journal of Endocrinology. 2018. 1–7. 6 indexed citations

20.

Nabrdalik, Katarzyna, et al.. (2017). Amelioration of liver function and glucose control with pioglitazone in a patient with diabetes mellitus type 2 and nonalcoholic fatty liver disease. Clinical Diabetology. 5(6). 199–202. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact